MiMedx
Price & Volume
Stats
See moreOpen | $3.18 |
Previous Close | $3.20 |
Day Range | $3.08-$3.26 |
52W Range | $3.03-$7.92 |
Market Cap | $474.2M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $303.7M |
Revenue Growth (YoY) | -45.2% |
Gross Profit (12 Mos) | $234.7M |
Diluted EPS | -$0.13 |
News
See moreYahoo Finance • 3 months ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)
Yahoo Finance • 3 months ago
MIMEDX Announces Second Quarter 2026 Operating & Financial Results
Yahoo Finance • 6 months ago
Mimedx expects $260M-$290M 2026 net sales amid $40M cost cuts and wound care reimbursement disruption
Yahoo Finance • 6 months ago
Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)
About
CEO | Mr. Joseph H. Capper |
Address | 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 808 |